Survival in treated idiopathic normal pressure hydrocephalus.


Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 27 08 2019
accepted: 19 10 2019
pubmed: 13 11 2019
medline: 24 11 2020
entrez: 13 11 2019
Statut: ppublish

Résumé

To describe survival and causes of death in 979 treated iNPH patients from the Swedish Hydrocephalus Quality Registry (SHQR), and to examine the influence of comorbidities, symptom severity and postoperative outcome. All 979 patients operated for iNPH 2004-2011 and registered in the SHQR were included. A matched control group of 4890 persons from the general population was selected by Statistics Sweden. Data from the Swedish Cause of Death Registry was obtained for patients and controls. At a median 5.9 (IQR 4.2-8.1) year follow-up, 37% of the iNPH patients and 23% of the controls had died. Mortality was increased in iNPH patients by a hazard ratio of 1.81, 95% CI 1.61-2.04, p < 0.001. More pronounced symptoms in the preoperative ordinal gait scale and the Mini-mental State Examination were the most important independent predictors of mortality along with the prevalence of heart disease. Patients who improved in both the gait scale and in the modified Rankin Scale postoperatively (n = 144) had a similar survival as the general population (p = 0.391). Deaths due to cerebrovascular disease or dementia were more common in iNPH patients, while more controls died because of neoplasms or disorders of the circulatory system. Mortality in operated iNPH patients is 1.8 times increased compared to the general population, a lower figure than previously reported. The survival of iNPH patients who improve in gait and functional independence is similar to that of the general population, indicating that shunt surgery for iNPH, besides improving symptoms and signs, can normalize survival.

Identifiants

pubmed: 31713102
doi: 10.1007/s00415-019-09598-1
pii: 10.1007/s00415-019-09598-1
pmc: PMC7035239
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

640-648

Subventions

Organisme : Stiftelsen Edit Jakobssons Donationsfond
ID : 2015-018
Organisme : The Gothenburg Medical Society
ID : GLS-503421
Organisme : Swedish State Support for Clinical Research (LUA-ALF)
ID : ALFGBG-592841
Organisme : Gothenburg Foundation for Neurological Research (ISNF)
ID : 1155

Références

J Neurol Sci. 2018 Aug 15;391:54-60
pubmed: 30103972
J Neurol Neurosurg Psychiatry. 2014 Jul;85(7):806-10
pubmed: 24292998
Fluids Barriers CNS. 2014 Aug 19;11:19
pubmed: 25180074
PLoS One. 2019 May 29;14(5):e0217705
pubmed: 31141553
Neurology. 2017 Feb 7;88(6):577-585
pubmed: 28062721
Acta Neurochir (Wien). 2013 Oct;155(10):1977-80
pubmed: 23975646
Acta Neurochir (Wien). 2002 Jun;144(6):515-23; discussion 523
pubmed: 12111484
Br J Neurosurg. 2017 Feb;31(1):21-27
pubmed: 27619731
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Neurology. 2016 Feb 16;86(7):592-9
pubmed: 26773072
Scott Med J. 1957 May;2(5):200-15
pubmed: 13432835
J Neurol. 2018 Jan;265(1):178-186
pubmed: 29188384
Control Clin Trials. 1996 Aug;17(4):343-6
pubmed: 8889347
Neurology. 2016 Feb 16;86(7):588-9
pubmed: 26773075
Acta Neurol Scand. 2008 Jul;118(1):48-53
pubmed: 18205881
Neurosurgery. 2006 Sep;59(3):545-52; discussion 545-52
pubmed: 16955036
Br J Neurosurg. 2006 Aug;20(4):214-21
pubmed: 16954071
Acta Neurol Scand. 2012 Oct;126(4):229-37
pubmed: 22587624
World Neurosurg. 2018 Apr;112:e624-e631
pubmed: 29374607
Stroke. 1988 May;19(5):604-7
pubmed: 3363593
Acta Neurochir (Wien). 2018 Mar;160(3):509-518
pubmed: 29150794
Acta Neurol Scand. 2009 Nov;120(5):314-6
pubmed: 19832773
Neurology. 2014 Apr 22;82(16):1449-54
pubmed: 24682964
Acta Neurol Scand. 2012 Sep;126(3):145-53
pubmed: 22571428
Neurology. 2000 Aug 22;55(4):576-8
pubmed: 10953197
Alzheimers Dement. 2017 Aug;13(8):850-857
pubmed: 28238737
Neurosurgery. 2010 Aug;67(2):295-301
pubmed: 20644414

Auteurs

Kerstin Andrén (K)

Hydrocephalus Research Unit, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Blå Stråket 7, 413 45, Gothenburg, Sweden. kerstin.andren@neuro.gu.se.

Carsten Wikkelsø (C)

Hydrocephalus Research Unit, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Blå Stråket 7, 413 45, Gothenburg, Sweden.

Nina Sundström (N)

Department of Radiation Sciences, Biomedical Engineering, Umeå University, Umeå, Sweden.

Hanna Israelsson (H)

Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden.

Simon Agerskov (S)

Hydrocephalus Research Unit, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Blå Stråket 7, 413 45, Gothenburg, Sweden.

Katarina Laurell (K)

Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden.
Department of Neuroscience, Uppsala University, Uppsala, Sweden.

Per Hellström (P)

Hydrocephalus Research Unit, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Blå Stråket 7, 413 45, Gothenburg, Sweden.

Mats Tullberg (M)

Hydrocephalus Research Unit, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Blå Stråket 7, 413 45, Gothenburg, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH